| Metabolic regulation of apoptosis in cancer K Matsuura, K Canfield, W Feng, M Kurokawa International review of cell and molecular biology 327, 43-87, 2016 | 215 | 2016 |
| CD36-mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-targeted therapies WW Feng, O Wilkins, S Bang, M Ung, J Li, J An, C Del Genio, K Canfield, ... Cell reports 29 (11), 3405-3420. e5, 2019 | 184 | 2019 |
| An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer C To, TS Beyett, J Jang, WW Feng, M Bahcall, HM Haikala, BH Shin, ... Nature cancer 3 (4), 402-417, 2022 | 105 | 2022 |
| Endocytosis of very low-density lipoproteins: an unexpected mechanism for lipid acquisition by breast cancer cells LE Lupien, K Bloch, J Dehairs, NA Traphagen, WW Feng, WL Davis, ... Journal of lipid research 61 (2), 205-218, 2020 | 52 | 2020 |
| Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer FJ de Miguel, C Gentile, WW Feng, SJ Silva, A Sankar, F Exposito, ... Cancer Cell 41 (8), 1516-1534. e9, 2023 | 45 | 2023 |
| Lipid metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer WW Feng, M Kurokawa Cancer Drug Resistance 3 (1), 1, 2020 | 45 | 2020 |
| The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target WW Feng, HT Zuppe, M Kurokawa Cells 12 (12), 1605, 2023 | 35 | 2023 |
| Methods for efficient analysis of tocopherols, tocotrienols and their metabolites in animal samples with HPLC-EC MJ Lee, W Feng, L Yang, YK Chen, E Chi, A Liu, CS Yang journal of food and drug analysis 26 (1), 318-329, 2018 | 21 | 2018 |
| Macrocyclization of quinazoline-based EGFR inhibitors leads to exclusive mutant selectivity for EGFR L858R and Del19 JA Amrhein, TS Beyett, WW Feng, A Krämer, J Weckesser, IK Schaeffner, ... Journal of Medicinal Chemistry 65 (23), 15679-15697, 2022 | 19 | 2022 |
| Transferrin Receptor Targeting Chimeras (TransTACs) for Membrane Protein Degradation D Zhang, J Duque-Jimenez, G Brixi, F Facchinetti, K Rhee, WW Feng, ... BioRxiv, 2023.08. 10.552782, 2023 | 15 | 2023 |
| X-linked Huwe1 is essential for oocyte maturation and preimplantation embryo development AA Eisa, S Bang, KJ Crawford, EM Murphy, WW Feng, S Dey, W Wells, ... Iscience 23 (9), 2020 | 13 | 2020 |
| CD36: a key mediator of resistance to HER2 inhibitors in breast cancer WW Feng, S Bang, M Kurokawa Molecular & Cellular Oncology 7 (2), 1715766, 2020 | 11 | 2020 |
| Transferrin receptor targeting chimeras for membrane protein degradation D Zhang, J Duque-Jimenez, F Facchinetti, G Brixi, K Rhee, WW Feng, ... Nature, 1-9, 2024 | 9 | 2024 |
| Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors F Pecci, S Nakazawa, B Ricciuti, G Harada, JK Lee, JV Alessi, ... Cancer Discovery 14 (8), 1440-1456, 2024 | 9 | 2024 |
| Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment B Alsaed, L Lin, J Son, J Li, J Smolander, T Lopez, PÖ Eser, A Ogino, ... Nature Communications 16 (1), 28, 2025 | 2 | 2025 |
| Parsing digital or analog TCR performance through piconewton forces A Akitsu, E Kobayashi, Y Feng, HM Stephens, KN Brazin, DJ Masi, ... Science Advances 10 (33), eado4313, 2024 | 2 | 2024 |
| MA07. 06 Eradicating Drug Tolerant Persisters (DTPs) In EGFR-Mutated Non Small Cell Lung Cancer (NSCLC) By Targeting TROP2 S Baldacci, EJ Brea, F Facchinetti, S Malhotra, M Tolstorukov, M Booker, ... Journal of Thoracic Oncology 19 (10), S80, 2024 | | 2024 |
| P3. 12C. 02 MET Fusions in NSCLC: Prevalence, Oncogenicity, and Resistance Mechanism S Nakazawa, F Pecci, D Gazgalis, F Gottlieb, B Ricciuti, J Alessi, ... Journal of Thoracic Oncology 19 (10), S341-S342, 2024 | | 2024 |
| Osimertinib-induced epigenetic and transcriptional reprogramming drives a BRD4-POUF-PDGFRB-YAP-EMT axis of resistance in NSCLC AV Hartley, C Weston, S Baldacci, W Feng, M Al-Dulaimi, C Gentile, ... Cancer Research 84 (6_Supplement), 3220-3220, 2024 | | 2024 |
| Hepatic Huwe1 loss protects mice from non-alcoholic fatty liver disease through lipid metabolic rewiring WW Feng, S Bang, EM Takacs, C Day, KJ Crawford, R Al-Sheyab, ... Iscience 26 (12), 2023 | | 2023 |
